Trial Profile
Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B : a Real Life Multicenter Cohort Study in Korea
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 29 Jan 2019 Status changed from active, no longer recruiting to completed.
- 24 Oct 2017 Results presented at The Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases
- 24 Oct 2017 Status changed from recruiting to active, no longer recruiting, according to the results presented at The Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases